- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Debt | Q2 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q2 2025 · Sep 30, 2024 | $30.36M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $568.62M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $448.69M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $388.17M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $472.1M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $1.35B |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $1.26B |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $1.77B |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $1.3B |
| Current Assets | Q2 2025 · Mar 31, 2025 | $2.03B |
| Current Assets | Q2 2025 · Sep 30, 2024 | $1.68B |
| Total Assets | Q2 2025 · Mar 31, 2025 | $2.27B |
| Total Assets | Q2 2025 · Sep 30, 2024 | $1.9B |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 126.84M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 123.96M sh |
| Capex | Q2 2025 · Mar 31, 2024 | $2.47M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $90.25M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.07 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.21 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.07 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.21 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $44.07M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $81.8M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $17.43M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $32.87M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$9.17M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$25.91M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $64.18M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $100.57M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $558.96M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $886.53M |
| Revenue | Q2 2025 · Mar 31, 2024 | $623.14M |
| Revenue | Q2 2025 · Mar 31, 2024 | $987.1M |